465 related articles for article (PubMed ID: 30929309)
1. Nrf2 in cancers: A double-edged sword.
Wu S; Lu H; Bai Y
Cancer Med; 2019 May; 8(5):2252-2267. PubMed ID: 30929309
[TBL] [Abstract][Full Text] [Related]
2. Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer.
Chen F; Xiao M; Hu S; Wang M
Front Oncol; 2024; 14():1381467. PubMed ID: 38634043
[TBL] [Abstract][Full Text] [Related]
3. The Role of Nrf2 Activity in Cancer Development and Progression.
Zimta AA; Cenariu D; Irimie A; Magdo L; Nabavi SM; Atanasov AG; Berindan-Neagoe I
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717324
[TBL] [Abstract][Full Text] [Related]
4. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.
Robledinos-Antón N; Fernández-Ginés R; Manda G; Cuadrado A
Oxid Med Cell Longev; 2019; 2019():9372182. PubMed ID: 31396308
[TBL] [Abstract][Full Text] [Related]
5. NRF2 as a regulator of cell metabolism and inflammation in cancer.
He F; Antonucci L; Karin M
Carcinogenesis; 2020 Jun; 41(4):405-416. PubMed ID: 32347301
[TBL] [Abstract][Full Text] [Related]
6. Potential Applications of NRF2 Inhibitors in Cancer Therapy.
Panieri E; Saso L
Oxid Med Cell Longev; 2019; 2019():8592348. PubMed ID: 31097977
[TBL] [Abstract][Full Text] [Related]
7. Potential Applications of NRF2 Modulators in Cancer Therapy.
Panieri E; Buha A; Telkoparan-Akillilar P; Cevik D; Kouretas D; Veskoukis A; Skaperda Z; Tsatsakis A; Wallace D; Suzen S; Saso L
Antioxidants (Basel); 2020 Feb; 9(3):. PubMed ID: 32106613
[TBL] [Abstract][Full Text] [Related]
8. "NRF2 addiction" in lung cancer cells and its impact on cancer therapy.
Hammad A; Namani A; Elshaer M; Wang XJ; Tang X
Cancer Lett; 2019 Dec; 467():40-49. PubMed ID: 31574294
[TBL] [Abstract][Full Text] [Related]
9. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway.
Baird L; Yamamoto M
Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284348
[TBL] [Abstract][Full Text] [Related]
10. Binding partners of NRF2: Functions and regulatory mechanisms.
Nam LB; Keum YS
Arch Biochem Biophys; 2019 Dec; 678():108184. PubMed ID: 31733215
[TBL] [Abstract][Full Text] [Related]
11. The Role of Nrf2 signaling in cancer stem cells: From stemness and self-renewal to tumorigenesis and chemoresistance.
Kahroba H; Shirmohamadi M; Hejazi MS; Samadi N
Life Sci; 2019 Dec; 239():116986. PubMed ID: 31678283
[TBL] [Abstract][Full Text] [Related]
12. Nrf2-ARE signaling in cellular protection: Mechanism of action and the regulatory mechanisms.
Shaw P; Chattopadhyay A
J Cell Physiol; 2020 Apr; 235(4):3119-3130. PubMed ID: 31549397
[TBL] [Abstract][Full Text] [Related]
13. Brusatol, an NRF2 inhibitor for future cancer therapeutic.
Cai SJ; Liu Y; Han S; Yang C
Cell Biosci; 2019; 9():45. PubMed ID: 31183074
[TBL] [Abstract][Full Text] [Related]
14. The Anti-Inflammatory and Anti-Oxidant Mechanisms of the Keap1/Nrf2/ARE Signaling Pathway in Chronic Diseases.
Tu W; Wang H; Li S; Liu Q; Sha H
Aging Dis; 2019 Jun; 10(3):637-651. PubMed ID: 31165007
[TBL] [Abstract][Full Text] [Related]
15. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
Garufi A; Baldari S; Pettinari R; Gilardini Montani MS; D'Orazi V; Pistritto G; Crispini A; Giorno E; Toietta G; Marchetti F; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2020 Jun; 39(1):122. PubMed ID: 32605658
[TBL] [Abstract][Full Text] [Related]
16. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.
Itoh K; Wakabayashi N; Katoh Y; Ishii T; Igarashi K; Engel JD; Yamamoto M
Genes Dev; 1999 Jan; 13(1):76-86. PubMed ID: 9887101
[TBL] [Abstract][Full Text] [Related]
17. Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects.
Galicia-Moreno M; Lucano-Landeros S; Monroy-Ramirez HC; Silva-Gomez J; Gutierrez-Cuevas J; Santos A; Armendariz-Borunda J
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33066023
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Nrf2/ARE Pathway by Dietary Flavonoids: A Friend or Foe for Cancer Management?
L Suraweera T; Rupasinghe HPV; Dellaire G; Xu Z
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33050575
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative Activity of Ursolic Acid in MDA-MB-231 Human Breast Cancer Cells through Nrf2 Pathway Regulation.
Zhang X; Li T; Gong ES; Liu RH
J Agric Food Chem; 2020 Jul; 68(28):7404-7415. PubMed ID: 32551573
[TBL] [Abstract][Full Text] [Related]
20. Broccoli or Sulforaphane: Is It the Source or Dose That Matters?
Yagishita Y; Fahey JW; Dinkova-Kostova AT; Kensler TW
Molecules; 2019 Oct; 24(19):. PubMed ID: 31590459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
